NCT04449549: Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
- State
- Under way
- Phase
- Phase 2
- People
- 82 planned
- Started
- 24 Aug 2020
- Primary completion
- 2 Apr 2027
- Arms
- 1
- Results
- None posted
- 29 Jun 2020: Trial registered
- 24 Aug 2020: Trial started